Theravance Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	840	956	466	541	732	823
Market Cap Growth	104.05%	105.25%	-13.88%	-26.14%	-11.02%	-28.05%
Enterprise Value	556.07	671.9	416.28	483.35	449.77	1,301
Last Close Price	16.31	18.71	9.41	11.24	11.22	11.05
PE Ratio	7.92	9.08	-8.18	-11.24	0.95	-3.85
Forward PE	6.46	25.83	-	-	-	-
PS Ratio	7.82	8.89	7.23	9.41	14.25	14.87
PB Ratio	2.81	3.22	2.65	2.54	1.66	-2.43
P/TBV Ratio	2.83	3.25	2.62	2.92	1.87	-2.27
P/FCF Ratio	3.52	4.01	-39.23	-18.33	-3.90	-3.89
P/OCF Ratio	3.52	4.01	-40.36	-20.02	-3.91	-3.96
EV/Sales Ratio	5.17	6.25	6.47	8.42	8.76	23.52
EV/EBITDA Ratio	-	329.53	-10.20	-9.69	-5.34	-5.22
EV/EBIT Ratio	-	-186.54	-8.87	-8.63	-4.89	-5.05
EV/FCF Ratio	2.33	2.82	-35.08	-16.39	-2.40	-6.16
Debt / Equity Ratio	0.11	0.11	0.22	0.21	0.10	-1.93
Debt / EBITDA Ratio	20.95	20.94	-1.22	-0.99	-0.62	-2.69
Debt / FCF Ratio	0.18	0.18	-4.20	-1.67	-0.28	-3.17
Net Debt / Equity Ratio	-0.92	-0.92	-0.22	-0.25	-0.62	-1.46
Net Debt / EBITDA Ratio	-133.78	-133.72	0.94	1.07	3.27	-1.99
Net Debt / FCF Ratio	-1.14	-1.14	3.25	1.81	1.47	-2.35
Asset Turnover	0.26	0.26	0.17	0.12	0.10	0.13
Quick Ratio	10.73	10.73	4.89	4.84	11.99	3.94
Current Ratio	10.93	10.93	5.02	5.39	12.31	4.26
Return on Equity (ROE)	38.86%	44.85%	-29.04%	-16.86%	-526.60%	82.53%
Return on Assets (ROA)	-0.61%	-0.70%	-16.13%	-12.69%	-54.83%	-61.06%
Return on Invested Capital (ROIC)	-1.27%	-1.47%	-22.88%	-23.89%	-128.01%	-200.58%
Return on Capital Employed (ROCE)	-0.94%	-0.94%	-13.82%	-11.97%	-20.55%	-77.91%
Earnings Yield	12.61%	11.01%	-12.22%	-8.90%	105.61%	-25.97%
FCF Yield	28.40%	24.96%	-2.55%	-5.45%	-25.63%	-25.69%
Buyback Yield / Dilution	-5.45%	-5.45%	11.67%	24.85%	-5.95%	-11.41%
Total Shareholder Return	-5.45%	-5.45%	11.67%	24.85%	-5.95%	-11.41%

Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q